Emavusertib
Emavusertib : Inhibitor of IRAK4
Structure
In Cells
(1
ratings)
In Model Organisms
(1
ratings)
note: The Chemical Probes Portal only endorses
compounds as chemical probes for use as specific and
selective modulators of the proposed target if they
receive three or more (3-4) stars.
Probe Emavusertib is in the process of SERP review.
Please continue to check back for new reviews and commentary.
Information
- up to 5 uM
- Reviewer recommended concentration: up to 1 µM to limit off-target effect (CLK-family)
Probe Availability:
SERP ratings and comments
SERP+ Ratings
In Cell Rating
In Model Organisms
SERP+ Comments:
The probe is generally well characterized and optimized for in vivo use. At 1 µM four other kinases (FLT3, CLK1, CLK2 and CLK4) are inhibited >90% (target inhibiton at this conectration = 82%). The compound is profiled extensively in model organisms (mouse, rat and dog) and has very good oral bioavailability. The in vivo activity was confirmed in xenograft models. A control compound is missing. At the moment (Mar 2023), it is one of the best tool compounds but care has to be taken regarding possible off-targets. The use of orthogonal probes is highly recommended.
(last updated: 22 Mar 2023 )